Neo Corporate PCL
Neo Corporate PCL operates in the household products industry, manufacturing and distributing personal care and household goods, primarily generating revenue through product sales in the consumer non-cyclicals sector.
Business. Neo Corporate PCL (NEO.BK) is a household products company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Analyst recommendations
3 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressDeborah K. Ross — Neogenomics, Inc.2021-12-30 · Democrat · NC · Purchase · $15,001 - $50,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Neo Corporate PCL (NEO.BK) is a household products company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Neo Corporate PCL maintains a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing, and a current ratio of 1.04, suggesting limited short-term liquidity cushion. The company's free cash flow is negative at -1371461860.0 THB, while capital expenditures amount to -2006381830.0 THB, reflecting significant reinvestment in operations. The liquidity risk is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt.
Profitability metrics show a return on equity of 10.89% and a return on assets of 4.85%, which are to be compared against industry benchmarks. The company's operating income of 813449330.0 THB and net income of 561740050.0 THB suggest a stable but not exceptional performance in terms of profitability.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic fluctuations and market-specific risks.
Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the current or next fiscal year. The company's capital expenditures and free cash flow suggest a focus on maintaining and expanding existing operations rather than aggressive growth.
The risk assessment indicates a low potential for dilution, with no immediate pressure for share issuance. However, the company's liquidity risk remains a concern due to the negative net cash position after accounting for total debt. The risk assessment also highlights the need for continued monitoring of the company's debt levels and cash flow management.
Recent events and filings have not indicated any major changes in the company's strategic direction or operational performance. Analysts have provided a mean price target of 20.93 THB, with a median of 20.60 THB, and all three recommendations are holds, indicating a neutral outlook from the investment community.
- Neo Corporate PCL has a moderate debt-to-equity ratio and a current ratio near 1, indicating limited short-term liquidity.
- The company's return on equity and return on assets are stable but not outstanding compared to industry benchmarks.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- Analysts have a neutral outlook, with all three recommendations being holds and no strong buy or sell ratings.
- The company's free cash flow is negative, and capital expenditures are high, suggesting a focus on reinvestment rather than growth.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,75 |
| Revenue | —no estimate | —no estimate | 11,4B THB |
| Operating income | —no estimate | —no estimate | 706,7M THB |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Unit → Common StockAcquired 14 125grant · 2026-06-23
- Director · Stock Option (Right to Buy) → Common StockAcquired 9 784 @ $11,20grant · 2026-06-23
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 5 893exercise · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 23 077exercise · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 23 077exercise · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 23 077exercise · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 23 077exercise · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 23 077exercise · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
- Director · Restricted Stock Unit → Common StockDisposed 22 964exercise · 2026-06-01
- Director · Restricted Stock Unit → Common StockAcquired 15 970grant · 2026-06-01
- Director · Stock Option (Right to Buy) → Common StockAcquired 11 069 @ $10,52grant · 2026-06-01
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Neo Corporate PCL Market data — financials · 2026-05-28
- Neo Corporate PCL Market data — analyst estimates · 2026-05-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,03 %$46M
- Institutional Investor · as of 2022-09-300,01 %$0M
- Investment Managers · as of 2026-03-310,00 %$20M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2025-12-310,00 %$163M
- Investment Managers · as of 2024-12-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$24M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$38M
- Investment Managers · as of 2026-03-310,00 %$7M
- Institutional Investor · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$16M
- Funds · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common StockSold 5 307 @ $11,10$59K · 2026-06-15
- Director · Common StockSold 5 307 @ $11,29$60K · 2026-06-09
- Director · Common StockOther 23 077 · 2026-06-01
- Director · Common StockOther 23 077 · 2026-06-01
- Director · Common StockOther 22 964 · 2026-06-01
- Director · Common StockOther 23 077 · 2026-06-01
- Director · Common StockOther 5 893 · 2026-06-01
- Director · Common StockOther 23 077 · 2026-06-01
- Director · Common StockOther 23 077 · 2026-06-01
- Director · Common StockOther 23 077 · 2026-06-01
- Pres & Chief Operating Officer · Common StockOther 3 783 · 2026-05-11
- EVP, GC & Business Development · Common StockOther 2 559 · 2026-05-11
- Pres & Chief Operating Officer · Common StockOther 5 830 · 2026-05-11
- EVP, GC & Business Development · Common StockOther 3 944 · 2026-05-11
- Pres & Chief Operating Officer · Common StockOther 2 349 · 2026-05-02
- Chief Accounting Officer · Common StockOther 5 372 · 2026-05-02
- Chief Accounting Officer · Common StockOther 1 309 · 2026-05-02
- Pres & Chief Operating Officer · Common StockOther 5 969 · 2026-05-02
- EVP, GC & Business Development · Common StockOther 1 042 · 2026-05-01
- Chief Accounting Officer · Common StockOther 937 · 2026-05-01
- Pres & Chief Operating Officer · Common StockOther 6 911 · 2026-04-01
- Director, Chief Executive Officer · Common StockOther 140 498 · 2026-04-01
- Director, Chief Executive Officer · Common StockOther 45 453 · 2026-04-01
- Pres & Chief Operating Officer · Common StockOther 17 562 · 2026-04-01
- Pres & Chief Operating Officer · Common StockOther 8 443 · 2026-02-23
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Debt-to-equity (FY 2025-12-31): 0.63xDerived (calculated)
- Return on equity (FY 2025-12-31): -12.9%Derived (calculated)
- Return on assets (FY 2025-12-31): -7.9%Derived (calculated)
- Current ratio (FY 2025-12-31): 4.26xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -34.2%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -56.5%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 11.5%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 8.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -36.7%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -25.5%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -25.8%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 19.0%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -7.3%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -17.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -28.9%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -36.8%Derived (calculated)
- Total assets (annual): USD 1.36BSEC XBRL filing
- Long-term debt (annual): USD 341.86MSEC XBRL filing
- Pre-tax income (annual): USD -110.27MSEC XBRL filing
- Cost of revenue (annual): USD 413.04MSEC XBRL filing
- Net income (annual): USD -108MSEC XBRL filing
- Shareholders' equity (annual): USD 836.56MSEC XBRL filing
- Cash & equivalents (annual): USD 159.62MSEC XBRL filing
- R&D expense (annual): USD 37.08MSEC XBRL filing